A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

NCT02443246 Phase 3 COMPLETED

To compare the efficacy of Vitamin D3 B.O.N. Intramuscular Injection within 12 weeks with that of placebo in adults with Vitamin D Deficiency.

Details

Lead sponsor	Kwang Dong Pharmaceutical co., ltd.
Phase	Phase 3
Status	COMPLETED
Enrolment	84
Start date	2014-11
Completion	2015-12

Conditions

• Vitamin D Deficiency

Interventions

• Vitamin D3 B.O.N. Injection (cholecalciferol 200,000IU)
• Placebo

Primary outcomes

• Primary Efficacy Endpoints (serum 25(OH)D concentration) — 12 weeks
  serum 25(OH)D concentration